Matrix Private Capital Group LLC Intra Cellular Therapies, Inc. Transaction History

Matrix Private Capital Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $274,560 - $416,676	-7,800 Closed	0 $0
Q3 2021 Feb 22, 2022	SELL	$28.72 - $42.49 $2,872 - $4,249	-100 Reduced 1.27%	7,800 $291,000
Q2 2021 Feb 22, 2022	SELL	$29.3 - $44.5 $64,460 - $97,900	-2,200 Reduced 21.78%	7,900 $322,000
Q1 2021 Feb 22, 2022	SELL	$30.8 - $39.51 $36,960 - $47,412	-1,200 Reduced 10.62%	10,100 $343,000
Q4 2020 Feb 22, 2022	SELL	$23.34 - $32.22 $11,670 - $16,110	-500 Reduced 4.24%	11,300 $359,000
Q3 2020 Feb 22, 2022	SELL	$17.61 - $31.86 $29,937 - $54,162	-1,700 Reduced 12.59%	11,800 $303,000
Q2 2020 Feb 22, 2022	BUY	$14.35 - $26.64 $21,525 - $39,960	1,500 Added 12.5%	13,500 $347,000
Q1 2020 Feb 22, 2022	BUY	$12.31 - $33.12 $147,720 - $397,439	12,000 New	12,000 $184,000

380

84M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Matrix Private Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Matrix Private Capital Group LLC with notifications on news.